HomePALI • NASDAQ
add
Palisade Bio Inc
Previous close
$2.00
Day range
$1.99 - $2.16
Year range
$0.53 - $2.64
Market cap
331.77M USD
Avg Volume
3.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.98M | 195.12% |
Net income | -8.90M | -166.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.98M | -195.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 133.38M | 1,256.50% |
Total assets | 134.34M | 1,134.78% |
Total liabilities | 4.96M | 46.52% |
Total equity | 129.38M | — |
Shares outstanding | 165.88M | — |
Price to book | 2.47 | — |
Return on assets | -35.31% | — |
Return on capital | -37.56% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.90M | -166.12% |
Cash from operations | -3.14M | -32.05% |
Cash from investing | — | — |
Cash from financing | 131.33M | 3,055.48% |
Net change in cash | 128.19M | 7,097.47% |
Free cash flow | -4.40M | -286.82% |
About
Founded
2005
Headquarters
Website
Employees
8
